Merck (MRK) Gains from Investment Securities (2009 - 2026)
Merck (MRK) reported Gains from Investment Securities of $66.0 million for Q1 2026, up 160.55% year-over-year from $25.3 million in Q1 2025, and down 61.63% on a QoQ basis from $172.0 million in Q4 2025.
Merck (MRK) has 18 years of Gains from Investment Securities data on file, last reported at $66.0 million in Q1 2026.
- Quarterly Gains from Investment Securities rose 160.55% year-over-year to $66.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $233.0 million (up 5725.0% YoY) and the FY2025 annual result came in at $58.0 million, down 54.33% from the prior year.
- Gains from Investment Securities slipped to $66.0 million in Q1 2026 per MRK's latest filing, from $172.0 million in the prior quarter.
- Across five years, Gains from Investment Securities topped out at $330.0 million in Q3 2025 and bottomed at -$975.0 million in Q3 2022.
- The 5-year median for Gains from Investment Securities is $14.0 million (2024), against an average of -$59.6 million.
- Peak annual rise in Gains from Investment Securities reached 243.07% in 2024, while the deepest fall reached 1265.0% in 2024.
- Tracing MRK's Gains from Investment Securities over 5 years: stood at -$132.0 million in 2022, then surged by 115.91% to $21.0 million in 2023, then surged by 171.43% to $57.0 million in 2024, then jumped by 201.75% to $172.0 million in 2025, then sank by 61.63% to $66.0 million in 2026.
- Per Business Quant, the three latest MRK Gains from Investment Securities figures stand at $66.0 million (Q1 2026), $172.0 million (Q4 2025), and $330.0 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Novartis Ag | 107,124,802.25 Bn | 107,124,802.25 Bn | - |
| 2 | Eli Lilly | 969.00 Bn | 963.72 Bn | 16.22 Bn |
| 3 | Johnson & Johnson | 539.46 Bn | 517.41 Bn | 15.96 Bn |
| 4 | AbbVie | 376.92 Bn | 367.57 Bn | 10.78 Bn |
| 5 | Merck | 285.00 Bn | 279.35 Bn | 12.09 Bn |
| 6 | Amgen | 177.58 Bn | 165.55 Bn | 5.87 Bn |
| 7 | Gilead Sciences | 163.22 Bn | 155.50 Bn | 5.52 Bn |
| 8 | Pfizer | 145.86 Bn | 133.09 Bn | -1.21 Bn |
| 9 | Bristol Myers Squibb | 111.90 Bn | 101.44 Bn | 8.07 Bn |
| 10 | Gsk | 88.34 Bn | 83.66 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 66.00 Mn |
| Mar 31, 2026 | 66.00 Mn |
| Dec 31, 2025 | 172.00 Mn |
| Dec 31, 2025 | 172.00 Mn |
| Sep 30, 2025 | 330.00 Mn |
| Sep 30, 2025 | 330.00 Mn |
| Jun 30, 2025 | -335.00 Mn |
| Jun 30, 2025 | -335.00 Mn |
| Mar 31, 2025 | -109.00 Mn |
| Mar 31, 2025 | -109.00 Mn |
| Dec 31, 2024 | 57.00 Mn |
| Dec 31, 2024 | 57.00 Mn |
| Sep 30, 2024 | -233.00 Mn |
| Sep 30, 2024 | -233.00 Mn |
| Jun 30, 2024 | 289.00 Mn |
| Jun 30, 2024 | 289.00 Mn |
| Mar 31, 2024 | 14.00 Mn |
| Mar 31, 2024 | 14.00 Mn |
| Dec 31, 2023 | 21.00 Mn |
| Dec 31, 2023 | 21.00 Mn |
| Sep 30, 2023 | 20.00 Mn |
| Sep 30, 2023 | 20.00 Mn |
| Jun 30, 2023 | -202.00 Mn |
| Jun 30, 2023 | -202.00 Mn |
| Mar 31, 2023 | 197.00 Mn |
| Mar 31, 2023 | 197.00 Mn |
| Dec 31, 2022 | -132.00 Mn |
| Dec 31, 2022 | -132.00 Mn |
| Sep 30, 2022 | -975.00 Mn |
| Sep 30, 2022 | -975.00 Mn |
| Jun 30, 2022 | -51.00 Mn |
| Jun 30, 2022 | -51.00 Mn |
| Mar 31, 2022 | -143.00 Mn |
| Mar 31, 2022 | -143.00 Mn |
| Dec 31, 2021 | -790.00 Mn |
| Dec 31, 2021 | -790.00 Mn |
| Sep 30, 2021 | 313.00 Mn |
| Sep 30, 2021 | 313.00 Mn |
| Jun 30, 2021 | -92.00 Mn |
| Jun 30, 2021 | -92.00 Mn |
| Mar 31, 2021 | -236.00 Mn |
| Mar 31, 2021 | -236.00 Mn |
| Dec 31, 2020 | 394.00 Mn |
| Dec 31, 2020 | 394.00 Mn |
| Sep 30, 2020 | -723.00 Mn |
| Sep 30, 2020 | -723.00 Mn |
| Jun 30, 2020 | 340.00 Mn |
| Jun 30, 2020 | 340.00 Mn |
| Mar 31, 2020 | -136.00 Mn |
| Mar 31, 2020 | -136.00 Mn |
| Dec 31, 2019 | -34.00 Mn |
| Dec 31, 2019 | -34.00 Mn |
| Sep 30, 2019 | -235.00 Mn |
| Sep 30, 2019 | -235.00 Mn |
| Jun 30, 2019 | 35.00 Mn |
| Jun 30, 2019 | 35.00 Mn |
| Mar 31, 2019 | -120.00 Mn |
| Mar 31, 2019 | -120.00 Mn |
| Dec 31, 2018 | -1.13 Bn |
| Dec 31, 2018 | -1.13 Bn |
| Sep 30, 2018 | 515.00 Mn |
| Sep 30, 2018 | 515.00 Mn |
| Jun 30, 2018 | -315.00 Mn |
| Jun 30, 2018 | -315.00 Mn |
| Mar 31, 2018 | -50.00 Mn |
| Mar 31, 2018 | -50.00 Mn |
| Dec 31, 2017 | 83.00 Mn |
| Dec 31, 2017 | 83.00 Mn |
| Sep 30, 2017 | -58.00 Mn |
| Sep 30, 2017 | -58.00 Mn |
| Jun 30, 2017 | -91.00 Mn |
| Jun 30, 2017 | -91.00 Mn |
| Mar 31, 2017 | 28.00 Mn |
| Mar 31, 2017 | 28.00 Mn |
| Dec 31, 2016 | -13.00 Mn |
| Dec 31, 2016 | -13.00 Mn |
| Sep 30, 2016 | -179.00 Mn |
| Sep 30, 2016 | -179.00 Mn |
| Jun 30, 2016 | 61.00 Mn |
| Jun 30, 2016 | 61.00 Mn |
| Mar 31, 2016 | -82.00 Mn |
| Mar 31, 2016 | -82.00 Mn |
| Dec 31, 2015 | -233.00 Mn |
| Dec 31, 2015 | -233.00 Mn |
| Sep 30, 2015 | -28.00 Mn |
| Sep 30, 2015 | -28.00 Mn |
| Jun 30, 2015 | 37.00 Mn |
| Jun 30, 2015 | 37.00 Mn |
| Mar 31, 2015 | 3.00 Mn |
| Mar 31, 2015 | 3.00 Mn |
| Dec 31, 2014 | 53.00 Mn |
| Dec 31, 2014 | 53.00 Mn |
| Sep 30, 2014 | 84.00 Mn |
| Sep 30, 2014 | 84.00 Mn |
| Jun 30, 2014 | 650.00 Mn |
| Jun 30, 2014 | 650.00 Mn |
| Mar 31, 2014 | -58.00 Mn |
| Mar 31, 2014 | -58.00 Mn |
| Dec 31, 2013 | 285.00 Mn |
| Dec 31, 2013 | 285.00 Mn |
| Sep 30, 2013 | 51.00 Mn |
| Sep 30, 2013 | 51.00 Mn |
| Jun 30, 2013 | -52.00 Mn |
| Jun 30, 2013 | -52.00 Mn |
| Mar 31, 2013 | 32,000.00 |
| Mar 31, 2013 | 32,000.00 |
| Dec 31, 2012 | 110.00 Mn |
| Dec 31, 2012 | 110.00 Mn |
| Sep 30, 2012 | 7.00 Mn |
| Sep 30, 2012 | 7.00 Mn |
| Jun 30, 2012 | -154.00 Mn |
| Jun 30, 2012 | -154.00 Mn |
| Mar 31, 2012 | 11.00 Mn |
| Mar 31, 2012 | 11.00 Mn |
| Dec 31, 2011 | -530.00 Mn |
| Dec 31, 2011 | -530.00 Mn |
| Sep 30, 2011 | 8.00 Mn |
| Sep 30, 2011 | 8.00 Mn |
| Jun 30, 2011 | 234.00 Mn |
| Jun 30, 2011 | 234.00 Mn |
| Mar 31, 2011 | 222.00 Mn |
| Mar 31, 2011 | 222.00 Mn |
| Dec 31, 2010 | 60.00 Mn |
| Dec 31, 2010 | 60.00 Mn |
| Sep 30, 2010 | 674.00 Mn |
| Sep 30, 2010 | 674.00 Mn |
| Jun 30, 2010 | -487.00 Mn |
| Jun 30, 2010 | -487.00 Mn |
| Mar 31, 2010 | 77.00 Mn |
| Mar 31, 2010 | 77.00 Mn |
| Dec 31, 2009 | -177.90 Mn |
| Dec 31, 2009 | -177.90 Mn |
| Sep 30, 2009 | 2.76 Bn |
| Sep 30, 2009 | 2.76 Bn |
| Jun 30, 2009 | -94.60 Mn |
| Jun 30, 2009 | -94.60 Mn |
| Mar 31, 2009 | 90.50 Mn |
| Mar 31, 2009 | 90.50 Mn |